GovChime
Notice ID: de9784e0e494248c113d296e61e5102eAward NoticeAwarded

The NIH NeuroBioBank Brain and Tissue Repository

Awarded on August 30, 2019. Full description on SAM.gov.

Awarded tounder 75N95019C00045 (source: SAM.gov award notice)• $9.7M

Overview

Posted
September 20, 2019
Notice type
Award Notice
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)

Notice details

PSC
A: RESEARCH AND DEVELOPMENT
Last updated
Sep 25, 2026
Award date
Aug 30, 2019
Award amount (SAM.gov award notice)
$9.7M

Identifiers

Solicitation number
75N95019R00006
Notice ID
de9784e0e494248c113d296e61e5102e
Award number (PIID)
75N95019C00045

Description

The objective of this initiative is to increase the availability of human disease and control specimens for research (brain and central nervous system (CNS) tissues) by establishing contract collection site(s) to more efficiently acquire, curate, store, and distribute these specimens to qualified investigators. A broader objective is to increase proactive involvement of the disease advocacy and patient communities, with the ultimate goal of reducing the burden of nervous system disorders. The purpose of this contract is to establish collection sites(s) (i.e., the NIH Brain and Tissue Repository (NBTR)) to provide services that will actively acquire, receive, process, store, curate, preserve, and distribute CNS and related biological specimens to qualified investigators. Six competitive, cost-Reimbursement, LOE, R&D contracts for a base with four option years, and optional quantities within each year were awarded.

Full description on SAM.gov

Award Overview

Award Number

75N95019C00045

Award Amount (SAM.gov award notice)

$9.7M

Award Date

Aug 30, 2019

Awardee

Original Solicitation

Notice ID: de9784e0e494248c113d296e61e5102e

Posted Date: Sep 20, 2019

Original Response Deadline: Not specified

Contract Details

No FPDS record matches this award number at the same department yet

Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.

More From This Vendor

Top 5 most recent

4
  • 75N95026C00008
    GREATER LOS ANGELES VETERANS RESEARCH AND EDUCATION FOUNDATION
    Department of Health and Human ServicesNAICS 541714
    $3.8MSigned Oct 27, 2026
  • 75N95026C00008
    GREATER LOS ANGELES VETERANS RESEARCH AND EDUCATION FOUNDATION
    Department of Health and Human ServicesNAICS 541714
    $1.9MSigned Jul 28, 2026
  • 75N95026C00008
    GREATER LOS ANGELES VETERANS RESEARCH AND EDUCATION FOUNDATION
    Department of Health and Human ServicesNAICS 541714
    $1.9MSigned Dec 4, 2025
  • 75N95026C00008
    GREATER LOS ANGELES VETERANS RESEARCH AND EDUCATION FOUNDATION
    Department of Health and Human ServicesNAICS 541714
    —Signed Oct 31, 2025

Contacts

Contracting Officer

Primary Contact

Valerie Whipple
Contracting Officer

Secondary Contact

Robin Knightly
Contract Specialist

Documents

Select documents to download

Showing 3 of 3 items

Document
Source
Agency
Posted Date
File Size
Actions
SolicitationSAM.govSep 20, 2019-
SolicitationSAM.govSep 20, 2019-
SolicitationSAM.govSep 20, 2019-

Lifecycle

Solicitation:75N95019R00006
  1. Market Research
  2. Pre-Solicitation
  3. Solicitation
  4. Awarded

This opportunity has been awarded.

  1. Market ResearchOct 26, 2018

    The NIH NeuroBioBank

    Notice 2957f224bd6b9fbde205d54618caa4eb on SAM.gov

  2. 3×
    Pre-SolicitationJan 11, 2019

    THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY

    Notice 2659f430e8a3585de7534b43147ba37b on SAM.gov

  3. SolicitationMar 8, 2019

    THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY

    Notice a4cc89395e3dd51da59ad0971c0ed20d on SAM.gov

  4. 6×
    AwardedCurrentSep 7, 2019

    The NIH NeuroBioBank Brain and Tissue Repository

    Notice de9784e0e494248c113d296e61e5102e on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, TBIPRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future TBIPHRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the TBIPHRP or the Department of War (DoW). BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP TBIPHRP’s vision is to optimize the prevention, assessment, and treatment of psychological health conditions and/or traumatic brain injuries. The TBIPHRP’s mission is to fund research to understand, prevent and treat psychological health conditions and/or traumatic brain injuries that accelerates solutions to improve the health and healthcare of Service Members, their Families, Veterans, and the American public. Appropriations for the TBIPHRP from FY21-24 and FY26 totaled $740.5 million. As of October 2026, FY27 funds for the TBIPHRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the TBIPHRP. Additional information about the TBIPHRP can be found here: https://cdmrp.health.mil/tbiphrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-TBIPHRP-RFI
69%
Market Research12/11/2026
13 NOV: Amendment 1 provides minor revisions to the ISO (see orange text). The link to the SURPASS webinar has also been added to this posting. 30 SEP: The Advanced Research Projects Agency for Health (ARPA-H) posts this solicitation in support of its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program. ARPA-H anticipates multiple Other Transaction Agreement awards will result from this opportunity. Interested parties are invited to review the attached Solicitation (ARPA-H-SOL-26-164) and associated attachments. As detailed in Special Notice ARPA-H-SN-26-164, ARPA-H will host an informational webinar on 15 OCT 2026 and a 2-day Proposers’ Day on 6 and 9 NOV 2026 in support of SURPASS. All questions related to SURPASS should be submitted to SURPASS@ARPA-H.GOV.
55%
Solicitation11/30/2026
Pre-Solicitation Notice of Intent to Sole Source Contracting Activity: U.S. Environmental Protection Agency (EPA), Office of the Chief Procurement Officer (OCPO), Water, Tribal, and Science Division (WTSD) Description of Services: The EPA requires histology and pathology services of maternal and neonatal rodent specimen organs at the US EPA Headquarters, 1200 Pennsylvania Ave, Washington, DC 20460. Experimental Pathology Laboratories, Inc. (EPL) experience in the toxicologic pathology of environmental contaminants — including PFAS, phthalates, air pollutants, and endocrine-disrupting compounds — is highly relevant to the scope of this acquisition. EPA and other federal research offices have a long history of contracting histopathology services with EPL. Consequently, EPL has extensive experience meeting EPA’s Quality Assurance (QA) Program requirements. Its laboratories comply with Good Laboratory Practice (GLP) regulations and have passed GLP inspections by the FDA and EPA in the past decade. Importantly, the work proposed under this acquisition continues several larger studies previously processed and evaluated. Deviations from established protocols are unacceptable within the same or related studies, as they introduce unknown errors and compromise data integrity. Finally, EPL is a local vendor, allowing the program office to hand-deliver delicate samples in fixative (no shipping). This acquisition is anticipated to be a firm-fixed purchase order. The North American Industry Classification System (NAICS) code is 541714 – Research and Development in Biotechnology (except Nanobiotechnology). The product and service code (PSC) is AZ11 – R&D-Other Research and Development. Acquisition Procedures: The EPA intends to award a sole source purchase order to EPL in accordance with RFO FAR 6.103-1(b) and simplified acquisition procedures in accordance with FAR part 12. The sole source justification will be made publicly available in accordance with RFO FAR 6.301. EPL is the only known source able to satisfy this requirement. Notwithstanding, in accordance with RFO FAR 5.101(c)(4)(vi), responsible sources may elect to submit a capability statement, proposal, or quotation. A determination not to compete the proposed firm-fixed-price contract based upon the responses received to this notice is solely within the discretion of the Government. Responses to this notice must be submitted to the contracting officer, Paige Long, at long.paige@epa.gov no later than November 30, 2026. Telephone responses will not be honored. Estimated award date is December 3, 2026. FedConnect is a web portal that connects agencies and vendors to streamline the process of doing business with the federal government. Through FedConnect contractors will be able to receive, review and respond to contract pre- and post-award actions and documents such as correspondence, request for proposals, tasking instruments and contract modifications. The use of FedConnect also furthers the EPAs commitment to moving towards a paperless acquisition environment by reducing its carbon footprint and conducting its business in an ecologically friendly manner. There is no charge to use FedConnect. Vendors can register with FedConnect at www.fedconnect.net/FedConnect/. For assistance in registering or for other FedConnect technical questions please call the FedConnect Help Desk at (800) 899-6665 or email fcsupport@unisonglobal.com In addition, all vendors must be registered in the System for Award Management (SAM), as this facilitates registration for FedConnect. Please note that vendors MUST have their SAM profile set to public, otherwise FedConnect will not be able to access the SAM information required to validate vendor credentials. Registration may be completed and information regarding the registration process may be obtained at http://www.sam.gov. There is no charge for registration in SAM.
55%
Special Notice11/30/2026
The United States Department of Navy Medicine Research and Development Command (NMRDC) intends to award a sole source contract to, Illumina Inc., San Diego, CA. This notice is not a request for competitive proposals however If interested Government shall consider all responses. Illumina does not offer third party vendors. The NAICS code for this action is 541714. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a Unique Entity Identification Number (UEI). A Sam.gov number may be acquired free of charge by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220.
55%
Special Notice11/20/2026
The Defense Advanced Research Projects Agency (DARPA) will host a virtual Industry Day in support of the DARPA Program Solicitation (PS) for Laguna on December 9, 2026. DARPA anticipates releasing a draft of the program solicitation prior to Industry Day. When released, the solicitation will be made available at https://sam.gov/.
55%
Special Notice12/02/2026

Additional Details

Solicitation Number

75N95019R00006

Archive Date

Oct 5, 2019